These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30089595)

  • 61. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.
    Wang S; Shi J; Ye Z; Dong D; Yu D; Zhou M; Liu Y; Gevaert O; Wang K; Zhu Y; Zhou H; Liu Z; Tian J
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions.
    Asamura H; Suzuki K; Watanabe S; Matsuno Y; Maeshima A; Tsuchiya R
    Ann Thorac Surg; 2003 Oct; 76(4):1016-22. PubMed ID: 14529977
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidermal growth factor receptor mutations in Japanese men with lung adenocarcinomas.
    Tomita M; Ayabe T; Chosa E; Kawagoe K; Nakamura K
    Asian Pac J Cancer Prev; 2014; 15(24):10627-30. PubMed ID: 25605150
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
    Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
    Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic Value of Baseline 18F-FDG PET/CT Functional Parameters in Patients with Advanced Lung Adenocarcinoma Stratified by EGFR Mutation Status.
    Wang D; Zhang M; Gao X; Yu L
    PLoS One; 2016; 11(6):e0158307. PubMed ID: 27336755
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis.
    Cheng Z; Shan F; Yang Y; Shi Y; Zhang Z
    BMC Med Imaging; 2017 Jan; 17(1):5. PubMed ID: 28068946
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
    Saruwatari K; Ikemura S; Sekihara K; Kuwata T; Fujii S; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Ochiai A; Kohrogi H; Tsuboi M; Goto K; Ishii G
    Lung Cancer; 2016 Jan; 91():7-14. PubMed ID: 26711928
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
    AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
    Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Expression of epidermal growth factor receptor mutation specific antibodies in lung adenocarcinoma: evaluation of sensitivity, specificity and relationship to histologic subtypes].
    Lai YM; Feng Q; Sun Y; Wang P; Shi YF; Zhao M; Wu Q; Li XH
    Zhonghua Bing Li Xue Za Zhi; 2016 Sep; 45(9):606-11. PubMed ID: 27646888
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Retrospective analysis of icotinib neoadjuvant therapy of 63 lung cancer patients.
    Wang T; Liu Y; Zhou B; Hao S; Wang Z; Liang N; Liu J; Wang S
    Indian J Cancer; 2017; 54(1):215-222. PubMed ID: 29199694
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung.
    Matsuguma H; Nakahara R; Anraku M; Kondo T; Tsuura Y; Kamiyama Y; Mori K; Yokoi K
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):1102-6. PubMed ID: 15145016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Analysis of epidermal growth factor receptor mutations and its clinico-pathologic characteristics of the primary lung adenocarcinoma in Xinjiang Uighur Autonomous Region].
    Ma XM; Cao YZ; Ji WL; Zhao F; Fang XZ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Aug; 48(4):663-666. PubMed ID: 29263509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma.
    Qiu X; Yuan H; Sima B
    Thorac Cancer; 2019 Feb; 10(2):170-174. PubMed ID: 30516345
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
    Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
    Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1.
    Kumagai T; Tomita Y; Nakatsuka SI; Kimura M; Kunimasa K; Inoue T; Tamiya M; Nishino K; Susaki Y; Kusu T; Tokunaga T; Okami J; Higashiyama M; Imamura F
    Thorac Cancer; 2018 Apr; 9(4):466-471. PubMed ID: 29473311
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Computed tomography features of resected lung adenocarcinomas with spread through air spaces.
    Toyokawa G; Yamada Y; Tagawa T; Kamitani T; Yamasaki Y; Shimokawa M; Oda Y; Maehara Y
    J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1670-1676.e4. PubMed ID: 29961590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficacy of Platinum-Based Adjuvant Chemotherapy on Prognosis of Pathological Stage II/III Lung Adenocarcinoma based on EGFR Mutation Status: A Propensity Score Matching Analysis.
    Isaka T; Ito H; Nakayama H; Yokose T; Katayama K; Yamada K; Masuda M
    Mol Diagn Ther; 2019 Oct; 23(5):657-665. PubMed ID: 31347029
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CT-Guided Core Biopsy for Peripheral Sub-solid Pulmonary Nodules to Predict Predominant Histological and Aggressive Subtypes of Lung Adenocarcinoma.
    Tsai PC; Yeh YC; Hsu PK; Chen CK; Chou TY; Wu YC
    Ann Surg Oncol; 2020 Oct; 27(11):4405-4412. PubMed ID: 32361797
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
    Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
    Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.